NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $1.74 | Prev. Close $1.91 | Circuit Range N/A |
Day Range $1.71 - $1.91 | Year Range $1.58 - $3.83 | Volume 25,525 |
Average Traded $1.83 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $1.74 | $1.90 | +13.77% |
05-Feb-26 | $1.82 | $1.67 | -9.49% |
04-Feb-26 | $2.02 | $1.84 | -9.56% |
03-Feb-26 | $2.14 | $2.04 | -4.90% |
02-Feb-26 | $2.13 | $2.15 | +1.90% |
30-Jan-26 | $2.15 | $2.10 | -0.47% |
29-Jan-26 | $2.09 | $2.12 | +0.71% |